Martorell M 1
1. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
2. Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects
3. Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
4. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
5. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
6. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
7. The effects of thymoquinone on pancreatic cancer: Evidence from preclinical studies
8. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
9. Camellia sinensis: Insights on its molecular mechanisms of action towards nutraceutical, anticancer potential and other therapeutic applications
10. Global, regional, and national stillbirths at 20 weeks gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
11. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
12. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
13. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
14. Natural essential oils as a new therapeutic tool in colorectal cancer
15. Lasia spinosa Chemical Composition and Therapeutic Potential: A Literature-Based Review
16. Natural Compounds or Their Derivatives against Breast Cancer: A Computational Study
17. Propolis: An update on its chemistry and pharmacological applications
18. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
19. An updated overview of anticancer effects of alternariol and its derivatives: underlying molecular mechanisms
20. Neuropharmacological Effects of Quercetin: A Literature-Based Review
21. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
22. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
23. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
24. Rumex Species: Phytochemistry, Pharmacology and Nutritional Potential for Food and Health Applications
25. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
26. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
27. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
28. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
29. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
30. Nutraceutical Profiling, Bioactive Composition, and Biological Applications of Lepidium sativum L.
31. Anticancer properties of bromelain: State-of-the-art and recent trends
32. Phytates as a natural source for health promotion: A critical evaluation of clinical trials
33. Medicinal and mechanistic overview of artemisinin in the treatment of human diseases
34. Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects
35. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
36. Ficus plants: State of the art from a phytochemical, pharmacological, and toxicological perspective
37. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
38. Artemisia spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles
39. Bioactive compounds from Prosopis species as potential oxidative stress and inflammation modulators: an update on mechanisms
40. Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
41. Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy
42. Recent advances in the therapeutic potential of emodin for human health
43. Santalum Genus: Phytochemical constituents, biological activities and health promoting-effects
44. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
45. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
46. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
47. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
48. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
49. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
50. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
1 2